Harald Dinter

1.4k total citations
22 papers, 1.1k citations indexed

About

Harald Dinter is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Harald Dinter has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Harald Dinter's work include Inflammatory mediators and NSAID effects (5 papers), Phosphodiesterase function and regulation (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Harald Dinter is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Phosphodiesterase function and regulation (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Harald Dinter collaborates with scholars based in United States, Germany and Japan. Harald Dinter's co-authors include Karl‐Heinz Thierauch, Arndt Schottelius, Wolf‐Dieter Schleuning, Andrea Schmid, H. Häuser, Bruno Alicke, Sandra L. Biroc, Katherine A. Jones, Robert Chiu and Masayoshi Imagawa and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Cancer Research.

In The Last Decade

Harald Dinter

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald Dinter United States 17 590 276 233 183 149 22 1.1k
Clifford A. Rinehart United States 20 587 1.0× 252 0.9× 126 0.5× 79 0.4× 98 0.7× 36 1.1k
Sander H. Diks Netherlands 21 810 1.4× 166 0.6× 191 0.8× 80 0.4× 183 1.2× 46 1.4k
Gabriella Miklóssy United States 19 675 1.1× 511 1.9× 296 1.3× 110 0.6× 105 0.7× 28 1.5k
Lowell M. Greenbaum United States 24 641 1.1× 245 0.9× 201 0.9× 156 0.9× 126 0.8× 67 1.6k
Emi Nakashima Japan 14 332 0.6× 215 0.8× 270 1.2× 64 0.3× 195 1.3× 31 934
Rosamaria Ruggieri United States 18 1.1k 1.9× 331 1.2× 334 1.4× 96 0.5× 142 1.0× 35 1.7k
Ming‐Chei Maa Taiwan 22 956 1.6× 322 1.2× 378 1.6× 73 0.4× 173 1.2× 35 1.6k
Sarah Kraus Israel 19 642 1.1× 382 1.4× 344 1.5× 82 0.4× 196 1.3× 69 1.6k
Shing Leng Chan Singapore 22 977 1.7× 143 0.5× 375 1.6× 110 0.6× 258 1.7× 33 1.4k
Marta Martínez Spain 16 717 1.2× 177 0.6× 262 1.1× 64 0.3× 299 2.0× 28 1.2k

Countries citing papers authored by Harald Dinter

Since Specialization
Citations

This map shows the geographic impact of Harald Dinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Dinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Dinter more than expected).

Fields of papers citing papers by Harald Dinter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Dinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Dinter. The network helps show where Harald Dinter may publish in the future.

Co-authorship network of co-authors of Harald Dinter

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Dinter. A scholar is included among the top collaborators of Harald Dinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Dinter. Harald Dinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Xiaoyan, Babu Subramanyam, Nenad Sarapa, Sven Golfier, & Harald Dinter. (2016). Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors. PubMed. 3(2). 76–86. 41 indexed citations
2.
Zhao, Xiaoyan, et al.. (2008). Tomoregulin Internalization Confers Selective Cytotoxicity of Immunotoxins on Prostate Cancer Cells. Translational Oncology. 1(2). 102–109. 11 indexed citations
3.
Tedesco, Donato, Jianhua Zhang, Guita Lalehzadeh, et al.. (2007). The Ubiquitin-Conjugating Enzyme E2-EPF Is Overexpressed in Primary Breast Cancer and Modulates Sensitivity to Topoisomerase II Inhibition. Neoplasia. 9(7). 601–613. 45 indexed citations
4.
Schneider, Doug, Alicia Newton, Ying Zhu, et al.. (2006). Antibodies Neutralizing Hepsin Protease Activity Do Not Impact Cell Growth but Inhibit Invasion of Prostate and Ovarian Tumor Cells in Culture. Cancer Research. 66(7). 3611–3619. 60 indexed citations
5.
Schottelius, Arndt & Harald Dinter. (2006). Cytokines, NF-κB, Microenvironment, Intestinal Inflammation and Cancer. Cancer treatment and research. 130. 67–87. 111 indexed citations
6.
Han, Ying, Sandra L. Biroc, Weiwei Li, et al.. (2006). The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Molecular Cancer Therapeutics. 5(9). 2158–2164. 157 indexed citations
7.
Zajchowski, Deborah A., Sandra L. Biroc, Jens Hoffmann, et al.. (2005). Anti‐tumor efficacy of the nucleoside analog 1‐(2‐deoxy‐2‐fluoro‐4‐thio‐β‐D‐arabinofuranosyl) cytosine (4′‐thio‐FAC) in human pancreatic and ovarian tumor xenograft models. International Journal of Cancer. 114(6). 1002–1009. 7 indexed citations
8.
Feldman, Richard I., James M. Wu, Mark A. Polokoff, et al.. (2005). Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1. Journal of Biological Chemistry. 280(20). 19867–19874. 171 indexed citations
9.
Zhao, Xiaoyan, Doug Schneider, Sandra L. Biroc, et al.. (2005). Targeting Tomoregulin for Radioimmunotherapy of Prostate Cancer. Cancer Research. 65(7). 2846–2853. 21 indexed citations
10.
Dinter, Harald, Jenny Tse, Meredith Halks‐Miller, et al.. (2000). The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents. Journal of Neuroimmunology. 108(1-2). 136–146. 43 indexed citations
11.
Dinter, Harald. (2000). Phosphodiesterase Type 4 Inhibitors. BioDrugs. 13(2). 87–94. 16 indexed citations
12.
Pette, M., et al.. (1999). Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones. Journal of Neuroimmunology. 98(2). 147–156. 13 indexed citations
13.
Dinter, Harald, James Onuffer, Daryl Faulds, & H. Daniel Perez. (1997). Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis. Journal of Molecular Medicine. 75(2). 95–102. 18 indexed citations
14.
Jörres, Achim, Harald Dinter, Nicholas Topley, et al.. (1997). INHIBITION OF TUMOUR NECROSIS FACTOR PRODUCTION IN ENDOTOXIN-STIMULATED HUMAN MONONUCLEAR LEUKOCYTES BY THE PROSTACYCLIN ANALOGUE ILOPROST: CELLULAR MECHANISMS. Cytokine. 9(2). 119–125. 42 indexed citations
15.
Schmid, Andrea, Karl‐Heinz Thierauch, Wolf‐Dieter Schleuning, & Harald Dinter. (1995). Splice Variants of the Human EP3 Receptor for Prostaglandin E2. European Journal of Biochemistry. 228(1). 23–30. 81 indexed citations
16.
Schmid, Andrea, Karl‐Heinz Thierauch, Wolf‐Dieter Schleuning, & Harald Dinter. (1995). Splice Variants of the Human EP3 Receptor for Prostaglandin E2. European Journal of Biochemistry. 228(1). 23–30. 99 indexed citations
17.
Thierauch, Karl‐Heinz, et al.. (1994). Prostaglandins and their receptors. Journal of Hypertension. 12(1). 1???6–1???6. 38 indexed citations
18.
Thierauch, Karl‐Heinz, Harald Dinter, & Günter Stock. (1993). Prostaglandins and their receptors: I. Pharmacologic receptor description, metabolism and drug use. Journal of Hypertension. 11(12). 1315–1318. 7 indexed citations
19.
Krätzschmar, Jörn, Bernard Haendler, Peter Bringmann, et al.. (1992). High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells. Gene. 116(2). 281–284. 12 indexed citations
20.
Dinter, Harald & H. Häuser. (1987). Superinduction of the human interferon-beta promoter.. The EMBO Journal. 6(3). 599–604. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clifford A. Rinehart Breakdown of academic impact, for papers by Sander H. Diks Breakdown of academic impact, for papers by Gabriella Miklóssy Breakdown of academic impact, for papers by Lowell M. Greenbaum Breakdown of academic impact, for papers by Emi Nakashima Breakdown of academic impact, for papers by Rosamaria Ruggieri Breakdown of academic impact, for papers by Ming‐Chei Maa Breakdown of academic impact, for papers by Sarah Kraus Breakdown of academic impact, for papers by Shing Leng Chan Breakdown of academic impact, for papers by Marta Martínez
Rankless by CCL
2026